海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- A randomised double blind controlled trial of oral ephedrine/etilefrine in the prevention of recurrent (stuttering) attacks of priapism in sickle cell disease: a multicentre international study in older children and adults
- Sickle cell disease Haematological Disorders Sickle-cell disorders
- Nigeria, United Kingdom
- 2006-02-02
Not Recruiting
- Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in Egypt
- Polio Infections and Infestations Polio
- Egypt
- 2006-02-01
Not recruiting
- Phase 1/2 study of SIR-Spheres plus systemic chemotherapy with 5-fluorouracil, leucovorin and oxaliplatin in patients with liver metastases from colorectal carcinoma
- Unresectable liver metastases from colorectal carcinoma
- Australia
- 2006-01-04
Not recruiting
- A phase 1 multicentre open label dose-escalation study of unrelated, major histocompatibility (MHC)-unmatched mesenchymals stem cells (MSC) for the treatment of steroid refractory acute graft versus host disease in recipients of allogeneic heamatopoietic stem cell transplants
- Patients who have undergone a allogeneic stem cell transplant who have developed steroid refractory graft versus host disease
- Australia
- 2007-08-23
Not recruiting
- CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.
- Asthma
- Australia, Austria, Belgium, Bulgaria, Canada, Estonia, Finland, Germany, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, Netherlands, New Zealand, Spain, United Kingdom
- 2007-05-25
Not recruiting
- Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
- Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2
- Australia, Austria, Brazil, Chile, Colombia, Costa Rica, Denmark, Finland, France, Germany, Guatemala, Hungary, India, Israel, Italy, Jordan, Korea, Republic of, Lebanon, Malaysia, Mexico, New Zealand, Norway, Peru, Philippines, Russian Federation, Saudi Arabia, South Africa, Sweden, Taiwan, United States
- 2008-10-03
Not Recruiting
- Prospective, randomized, non-blind, comparative with parallel groups, multicenter and multinational phase IH clinical study of the efficacy and safety of moxifloxacin 400 mg od sequential therapy versus amoxicillin/clavulanate 1 g IV tid followed by amoxicillin/clavulanate 625 mg PO tid for the treatment of complicated skin and skin structure infections during a 21-day period (Study 10279)
- -L089 Local infection of skin and subcutaneous tissue, unspecified Local infection of skin and subcutaneous tissue, unspecified;Local infection of skin and subcutaneous tissue, unspecified
- Argentina, Chile, Colombia, Germany, Hungary, Israel, Mexico, Peru, Philippines, South Africa, Spain, Taiwan
- 2001-03-30
Not recruiting
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)
- Hepatitis;Hepatitis C, Chronic;Fibrosis;Liver Cirrhosis;Hepatitis;Hepatitis C, Chronic;Fibrosis;Liver Cirrhosis;Hepatitis;Hepatitis C, Chronic;Fibrosis;Liver Cirrhosis;Hepatitis;Hepatitis C, Chronic;Fibrosis;Liver Cirrhosis
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2002-06-13
Not recruiting
- Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Head and Neck Cancer
- Australia, Peru, Puerto Rico, South Africa, United States
- 2003-02-05
Not recruiting
- TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.
- HIV
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Costa Rica, Denmark, France, Germany, Greece, Guatemala, Hungary, Italy, Malaysia, Mexico, Netherlands, Panama, Peru, Poland, Portugal, Puerto Rico, Russian Federation, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, Uganda, United Kingdom, United States, Venezuela
- 2005-11-22
Not recruiting
- Double-blind, Double-dummy, Randomised, Parallel-Arm Equivalence [Non-Inferiority] Study Comparing Hydromorphone Hydrochloride Extended-Release [HHER] Capsules to MS Contin Tablets, Dosed at a Ratio of 1:7.5 to relieve pain, in Cancer or Non-Cancer Patients with a History of Moderate to Severe Pain
- Moderate to severe pain
- Australia
- 2005-10-28
Not recruiting
- Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
- Hemophilia A;Hemophilia A;Hemophilia A;Hemophilia A
- Australia, Austria, Hungary, New Zealand, Poland, Romania, Sweden, United States
- 2005-10-20
Not Recruiting
- Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South Africa
- Poliomyelitis Infections and Infestations Poliomyelitis
- South Africa
- 2007-11-15
Not Recruiting
- A study involving an experimental drug named elvitegravir for the treatment of HIV-1 infection. The experimental drug or its comparator, named raltegravir, will be given in combination with a background regimen in subjects who are failing their current regimen of HIV medications. The first part of the study is a double-blind study, which means that neither you nor your study doctor will know which study drug you are receiving.
- Human Innunodeficiency Virus (HIV-1) Infections MedDRA version: 15.0 Level: LLT Classification code 10020192 Term: HIV-1 System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Belgium, Canada, France, Germany, Italy, Mexico, Netherlands, Portugal, Puerto Rico, Spain, United Kingdom, United States
- 2008-06-26
Not Recruiting
- IBCSG 35-07 / BIG 1-07 : Study of Letrozole Extension (SOLE). Letrozole in Preventing the Return of Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer.
- Endocrine Responsive Breast Cancer; Endocrine Responsive Breast Cancer;Cancer - Breast
- Australia, New Zealand
- 2008-05-12
Not recruiting
- Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A
- Severe Hemophilia A;Severe Hemophilia A;Severe Hemophilia A;Severe Hemophilia A
- Australia, Austria, Belgium, Brazil, Canada, France, Germany, Hong Kong, India, Israel, Italy, Japan, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2010-08-12
Not recruiting
- OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy
- Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2;Diabetes Mellitus, Type 2
- Austria, Canada, Czech Republic, France, Germany, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain, United States
- 2010-08-11
Not recruiting
- A Single Blinded Randomized Controlled Clinical Trial on the Efficacy of Ozone Therapy on Breast Cancer-Related Lymphedema
- breast cancer related lymphedema
- ,Outside, Egypt
- 2013-04-02
Not recruiting
- An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Romania, Russian Federation, South Africa, Spain, Taiwan, United Kingdom, United States
- 2016-07-08
Not Recruiting
- A trial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or without oral antidiabetic treatment in need of treatment intensification
- Diabetes Mellitus, Type 2 MedDRA version: 19.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Algeria, Czech Republic, India, Russian Federation, Serbia, Turkey, United States
- 2016-05-25